X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Lupin Ltd Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Lupin Ltd Quarterly Results   (LUPL)

Here are the latest quarterly results of Lupin Ltd. For more details, see the Lupin Ltd financial fact sheet and Lupin Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Lupin Ltd Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-16
*
3
Mar-17
*
3
Jun-17
3
Sep-17
3
Dec-17
3
Mar-18
3
Jun-18
3
Sep-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m44,82942,53324,99325,80025,31324,77625,79139,511 
Other income Rs m1,0364532797432405321,7252,307 
Turnover Rs m45,86542,98625,27226,54325,55225,30827,51641,817 
Expenses Rs m32,67035,12619,55920,38520,33120,23220,77834,014 
Gross profit Rs m12,1587,8135,4345,4154,9824,5455,0145,496 
Depreciation Rs m2,3092,6749519549921,0021,0452,655 
Interest Rs m45940662106679672738 
Profit before tax Rs m10,4265,1864,7005,0984,1623,9795,6224,410 
Tax Rs m4,0951,3671,1591,2091,0701,0541,3271,729 
Profit after tax Rs m6,3313,8193,5413,8893,0922,9254,2952,681 
Gross profit margin %27.118.421.721.019.718.319.413.9 
Effective tax rate %39.326.424.723.725.726.523.639.2 
Net profit margin %14.19.014.215.112.211.816.76.8 
Diluted EPS Rs 14.0 8.5 7.8 8.6 6.9 6.5 9.5 5.9  
Diluted EPS (TTM) Rs 66.2 56.7 45.0 39.0 31.8 29.8 31.5 28.8  
 Subscriber Feature View View View View View        
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Lupin Ltd 2QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   NATCO PHARMA  INDRAPRASTHA MEDICAL  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  INDOCO REMEDIES  

Compare LUPIN LTD With:   NATCO PHARMA  INDRAPRASTHA MEDICAL  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  INDOCO REMEDIES  

Compare LUPIN LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Will Low Inflation Encourage RBI to Cut Rates?(Podcast)

In a week full of macroeconomic developments, anxiety over third quarter results and trade war concerns, we take a look at the key topics that swayed the markets this week.

Views on news

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

LUPIN LTD Announces Quarterly Results (1QFY19); Net Profit Up 21.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, LUPIN LTD has posted a net profit of Rs 4 bn (up 21.3% YoY). Sales on the other hand came in at Rs 26 bn (up 3.2% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Our First Bluechip Stock Recommendation in Smart Money Secrets(The 5 Minute Wrapup)

Jan 9, 2019

For the first time, we have recommended a bluechip stock in Smart Money Secrets.

3 Stocks in Super Investor Sumeet Nagar's Portfolio That You Can Buy Right Now(The 5 Minute Wrapup)

Jan 11, 2019

The reasons that make these six stocks in Sumeet Nagar's portfolio so compelling

The Biggest Trend That I'm Seeing in the Market Today(The 5 Minute Wrapup)

Jan 10, 2019

For the first time ever, a majority of Indian households, will start to benefit from stock market wealth.

My First Stock Trading Recommendation For 2019(Profit Hunter)

Jan 10, 2019

My first trading recommendation for 2019 is a bluechip auto stock. Find out everything about it right away.

A Proven Super Investor Can Lead to Great Wealth(Profit Hunter)

Jan 7, 2019

Following a super investor can certainly help build a portfolio that can create significant wealth in the long term.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Jan 18, 2019 (Close)

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON LUPIN LTD

LUPIN LTD - MYLAN COMPARISON

COMPARE LUPIN LTD WITH

MARKET STATS